Mendelspod Podcast

The Case for a 6-Base Genome with Peter Fromen, CEO of Biomodal

28 Apr 2026

Contributed by Lukas

You’ve heard of 5-base genomics. How about 6-base? It turns out that separating 5-methylcytosine (mC) and 5-hydroxymethylcytosine (hmC) is pretty im...

The Next Frontier in Biology: Physics? Erdinc Sezgin of the Karolinska Institute

24 Apr 2026

Contributed by Lukas

There’s a famous line attributed to Ernest Rutherford, the father of nuclear physics: “All science is either physics or stamp collecting.” It’...

The Eligible But Under-Tested: Genomic Medicine in 2026 with Damon Hostin, Illumina

14 Apr 2026

Contributed by Lukas

What is the value of someone’s genome over their life? Is a genome today what it was 10 years ago? How does the adoption of genomic testing compar...

Spatial Transcriptomics Is Changing How We Do Biology: Fei Chen, The Broad Institute

09 Apr 2026

Contributed by Lukas

Fei Chen of the Broad Institute describes the original problem simply: genomics gave us powerful inventories of gene expression, while microscopy gave...

Beyond GLP-1: Why Peptides Are Back at the Center of Drug Discovery with Charlie Johannes and Tomi Sawyer

07 Apr 2026

Contributed by Lukas

Peptides are having a moment. But beneath the market excitement and the GLP-1 headlines, something more interesting is going on. A field that for year...

From the Archives: Inventor Mark Kokoris Debuts Roche’s New SBX Sequencer

02 Apr 2026

Contributed by Lukas

It was the biggest story in sequencing last year: Mark Kokoris, head of SBX sequencing at Roche and inventor of the technology, joins Mendelspod to ta...

Why Do Some Animals Live Ten Times Longer? Pursuing the Science of Aging with Steve Austad

17 Mar 2026

Contributed by Lukas

Why do some animals live ten times longer than others?That question opens today’s interview with Steve Austad, Distinguished Professor at the Univer...

MRD Testing: From Residual Disease to Real Decisions with Chris Hourigan and Gary Pestano

10 Mar 2026

Contributed by Lukas

Molecular residual disease, or MRD, has been part of oncology’s vocabulary for decades. But knowing something is there and being able to measure it...

Early vs Late Recurrence: How Multimodal AI Is Changing Breast Cancer Prognosis with George Sledge, Caris Life Sciences

05 Mar 2026

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comFor two decades, tests like Oncotype DX have helped oncologists decide...

The Dark Genome with Author Sudhakaran Prabakaran

03 Mar 2026

Contributed by Lukas

We began this podcast back around the time the ENCODE project announced that much of the genome was biochemically active. The big science project was...

Illumina's New Mapped Read Technology Provides Insights into Rare Disease: Stephen Kingsmore, Olivia Kim-McManus and Ali Crawford

26 Feb 2026

Contributed by Lukas

“We have been talking now for 15, 20 years about the diagnostic odyssey. That shouldn’t exist anymore. The new odyssey is the therapeutic odyssey....

CareDx’s Second Act with CEO John Hanna

17 Feb 2026

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comCareDx is a company on the move. For years, they have been a bellweth...

Inside GP2: Building a Global Genetic Map of Parkinson’s with Andrew Singleton and Ignacio Mata

10 Feb 2026

Contributed by Lukas

Large-scale genomics is back — and this time, it’s global by design.In this episode of Mendelspod, we return to the kind of ambitious, shared geno...

A Simple Sponge, a Big Shift in Cell Therapy with Yev Brudno, UNC

03 Feb 2026

Contributed by Lukas

What if the hardest part of scaling cell therapy turned out to be a materials problem not a biological one—and the solution looked like a sponge?On ...

How Cellanome Is Changing the Way We Study Cell Function with Matthew Spitzer and Pier Federico Gherardini

29 Jan 2026

Contributed by Lukas

For today’s show, we return to discussing the exciting new Cellanome platform. Joining Theral are Pier Federico Gherardini, VP of Computational Biol...

From Hereditary Risk to Residual Disease: Natera’s Integrated Vision for Precision Oncology with Adam ElNaggar, MD

28 Jan 2026

Contributed by Lukas

Half of oncologists in the U.S. are now ordering MRD testing, according to Adam ElNaggar, MD of Natera — but the other half, he says, “are still f...

The Rise of Geroscience with Alan Landay and Tom Blackwell, UTMB

22 Jan 2026

Contributed by Lukas

Aging may be the last great frontier of precision medicine—not a single disease, but the slow re-patterning of immunity, metabolism, and resilience ...

Unlocking the RNA Revolution: How Self-Replicating RNA Could Transform Vaccines and Therapeutics with Andrew Geall, Replicate Bioscience

15 Jan 2026

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comThe RNA revolution didn’t end with COVID. It’s only just beginning...

From Targets to Hits: The Emerging AI Ecosystem in Drug Discovery with Aqib Hasnain, Mithrl and Cheng Hu, Technetium Therapeutics

09 Jan 2026

Contributed by Lukas

Perhaps more than in any other field, AI is impacting drug discovery and development. To begin the year we’re joined by two AI software-as-service c...

Most Popular Show of 2025: How Certis Is Rewriting Cancer Models with CEO Peter Ellman

30 Dec 2025

Contributed by Lukas

In our most listened to episode this year, Certis Oncology CEO Peter Ellman breaks down how his company is reinventing cancer research by building ort...

Building the Front-End for Every Sequencer with Volta Labs CEO Udayan Umapathi

18 Dec 2025

Contributed by Lukas

As sequencing continues to become cheaper, more attention is being paid to sample prep. Today we’re following up with the company, Volta Labs, a ge...

A New Foundational Platform for Biology: Cellanome’s Debut with CEO Omead Ostadan

17 Dec 2025

Contributed by Lukas

Few startups have launched with such quiet anticipation—or such a remarkable founding pedigree—as Cellanome. Backed by veterans of the genomics re...

The Best of Times, the Worst of Times: Former NHGRI Director Eric Green on a Shaken NIH and Surging Genomic Science

11 Dec 2025

Contributed by Lukas

At the end of each year we look for a guest who in many ways defines the year. Today we sit down former NHGRI director Eric Green to reflect on the m...

From the Archives: Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz

09 Dec 2025

Contributed by Lukas

Note: This show was originally published on September 11, 2025. In light of the recent acquisition of Foresight Diagnostics by Natera, we’re re-pub...

Petter Brodin of Karolinska: How Spatial Interactomics Could Transform Autoimmune Therapy

04 Dec 2025

Contributed by Lukas

This week on Mendelspod, we speak with Petter Brodin, Professor of Pediatric Immunology at the Karolinska Institutet and Director of Systems Immunolog...

From GWAS to EWAS: Chirag Patel and and Gary Miller on the Rise of Exposomics

25 Nov 2025

Contributed by Lukas

What if the next leap in human health isn’t hidden in our genes, but in everything that happens to them? In this week’s truly groundbreaking Mende...

Agilent Partners with PacBio to Speed Adoption of Long Reads into Diagnostic Testing

20 Nov 2025

Contributed by Lukas

After more than a decade of success in research, long-read sequencing is more and more adopted into clinical testing. In today’s show, we speak with...

How AI Is Doing Science with Vivek Adarsh, CEO of Mithrl

18 Nov 2025

Contributed by Lukas

What used to take months of bioinformatics analysis can now happen in minutes—and with greater biological insight than ever before. In this episode,...

Inventor Mark Kokoris on Roche’s New Sequencing by Expansion

11 Nov 2025

Contributed by Lukas

The biggest story in sequencing this year lives up to the hype. Mark Kokoris, head of SBX sequencing at Roche and inventor of the technology, joins Me...

From Brewing Sake to Brewing Science: Takara Bio’s Bold New Chapter with CSO Andrew Farmer

04 Nov 2025

Contributed by Lukas

What company began as a sake manufacturer over a century ago and went on to launch the world’s first single-cell kit in 2011? It’s Takara Bio—a...

How Pathologists Can Lead in Precision Medicine with David Braxton

28 Oct 2025

Contributed by Lukas

When should a genetic test be ordered—and who decides? It’s a question we are constantly asking on the program. Dr. David Braxton, Chief of Molec...

From DNA to Proteins: Illumina Makes Its Proteomics Play - with Krishna Morampudi

21 Oct 2025

Contributed by Lukas

Illumina has just made a bold move into proteomics.In this episode of Mendelspod, Krishna Morampudi, Associate Director for Product Management at Illu...

Theranos Had the Vision. Truvian Has the Execution. Our Chat with CEO Jay Srinivasan

14 Oct 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comOn today’s debut interview with Truvian Health, CEO Jay Srinivasan l...

Physicians Don't Want a Laundry List of Genes says Premal Shah, CEO of Myome

07 Oct 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comPremal Shah says that many companies in personal genomics have emphasi...

The Customer Case for iconPCR with Stefan Green and Yann Jouvenot

02 Oct 2025

Contributed by Lukas

A few weeks back we featured a next gen PCR technology called iconPCR that carries the promise to dramatically impact research. Today we take a custo...

Alex Dickinson on Long Read Sequencing, Multi Omics, and the Next Frontier in Genomics

30 Sep 2025

Contributed by Lukas

Alex Dickinson, former Illumina executive and now host of The Geonomics Podcast, joins us for a wide-ranging conversation on the state of DNA sequenci...

Rapid Answers for Rare Disease: Katherine Stueland on GeneDx’s Mission

25 Sep 2025

Contributed by Lukas

In a time when many diagnostics companies are struggling, GeneDx is thriving by focusing squarely on solving one of medicine’s most pressing problem...

Moran Snir's Vision for Making Genomic Care Routine across the U.S.

23 Sep 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comFew founders get to build the future of genomics twice—Moran Snir is...

How Certis Is Rewriting Cancer Models with CEO Peter Ellman

18 Sep 2025

Contributed by Lukas

The story of Certis Oncology begins with a patient. In 2012, Barney Berglund was diagnosed with a rare sarcoma. Standard treatments failed him, and th...

Myriad’s Next Chapter: New CEO Sam Raha on Growth, AI, and MRD Testing

16 Sep 2025

Contributed by Lukas

For his first interview as CEO of Myriad Genetics, Sam Raha joined us to help kick off Mendelspod’s 15th season. Raha, who took the helm in April af...

Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz

11 Sep 2025

Contributed by Lukas

Catching a cancer relapse before any scan could see it is the ultimate goal for minimal residual disease or MRD testing. And it’s the promise behin...

Bodour Salhia and Danielle Goldberg: Rethinking Cancer Research with Illumina's 5-Base Solution

09 Sep 2025

Contributed by Lukas

Epigenetics has emerged as one of the most revealing windows into cancer biology. Long before genetic mutations appear, changes in DNA methylation can...

Reinventing PCR: Pranav Patel, N6 Tec

02 Sep 2025

Contributed by Lukas

Reinventing PCR, huh? That’s what we asked Pranav Patel, CEO and co-founder of N6 Tec, on today’s show. After all, PCR is one of the oldest tools ...

Making Whole Genome Sequencing the Universal Genetic Test - with David Ledbetter, Pediatric Rare Disease Institute, FSU

28 Aug 2025

Contributed by Lukas

Today we sit down with renowned geneticist David Ledbetter, whose pioneering work helped uncover the chromosomal basis of Prader-Willi, Angelman, and ...

Remembering Atul Butte with Marina Sirota, Chirag Patel and Mike Snyder

21 Aug 2025

Contributed by Lukas

In this special tribute episode, Mendelspod honors the life and legacy of Dr. Atul Butte (1969-2025), a towering figure in big data and precision medi...

The Age of Digital Pathology with Andy Beck, PathAI

14 Aug 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comMost cancer biomarkers aren’t found in your DNA—they’re found on...

What’s New for Regulatory Informatics in the Age of AI? Not Much—And That’s the Point with Raju Rayavarapu of DNAnexus

05 Aug 2025

Contributed by Lukas

In this episode of Mendelspod, we’re joined by Raju Rayavarapu, bioinformatician at DNAnexus and former FDA data specialist, to discuss how regulato...

From Illumina to Advocacy: Mike Kreitzinger on the Future of Clinical Genomics

31 Jul 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com“Genomics works. Don’t be scared of it.” That’s the message fr...

Amplifying the Expert: Jing Gao on Illumina's Connected Insights

30 Jul 2025

Contributed by Lukas

Illumina’s new interpretation software, Illumina Connected Insights, signals a turning point in oncology genomics—where sequencing power meets end...

The End of Animal Testing? Vivodyne Scales Human Tissue with CEO Andrei Georgescu

24 Jul 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comCan we finally replace animal testing in drug development—and still ...

How Liquid Biopsy Is Becoming Standard of Care with Rita Shaknovich, CMO, Agilent

23 Jul 2025

Contributed by Lukas

In this episode of Mendelspod, Theral welcomes Dr. Rita Shaknovich, Chief Medical Officer in Agilent’s Life Sciences and Diagnostics group, for a hi...

Tracking GMOs in the Gene Editing Era: Frédéric Debode on the Science of GMO Detection

17 Jul 2025

Contributed by Lukas

In this episode of Mendelspod, Theral speaks with Frédéric Debode, Scientific Director at CRA-W in Wallonia, Belgium, about the evolving landscape o...

From Discovery to Translation: Bruker's Bold New Play in Spatial with Joe Beechem and Oliver Braubach

10 Jul 2025

Contributed by Lukas

“We’re going to be rewriting the textbooks on how tissues work.”In this compelling reunion with spatial biology pioneer Joe Beechem and a first-...

Tagomics Wins NHS Grant, Unveils De-Methylation Platform for Early Cancer Testing with Rob Neely, CSO

01 Jul 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this episode of Mendelspod, Theral sits down with Rob Neely, co-fou...

From Paris to the Pentagon: Sophie Peresson Maps Biosecurity’s New Landscape

12 Jun 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this premium episode of Mendelspod, we’re joined by one of the fe...

From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision

05 Jun 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comAs artificial intelligence continues to influence the life sciences, s...

The Grammar of RNA: Gavin Knott on Gene Editing and Structural Biology in the Age of AI

29 May 2025

Contributed by Lukas

In this episode of Mendelspod, we plunge into the shape-shifting world of RNA with Dr. Gavin Knott, associate professor at Monash University and alum ...

The Third Way: Christian Schafmeister’s Spiroligomer Revolution

22 May 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comFor decades, drug discovery has followed two main roads: small molecul...

Can Math and AI Replace Some Biology in Drug Discovery? with Aridni Shah, Immunito AI

15 May 2025

Contributed by Lukas

What if drug design didn’t depend on pre-existing biological data? In this episode of Mendelspod, Theral sits down with Aridni Shah, co-founder and ...

$10 Genome, $8 Coffee: Rethinking the Economics of Life Science Tools with Stephane Budel, DeciBio

13 May 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comYes, the Trump economy has been tough on life science tools—but acco...

Quantum Scale: A New Era for Single-Cell Analysis with Giovanna Prout

08 May 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comOn today’s episode of Mendelspod, Theral sits down with Giovanna Pr...

Building Intuition at the Nanoscale: Steve McCloskey of Nanome on the VR Future of Science

01 May 2025

Contributed by Lukas

What if you could step inside a molecule? On today’s episode of Mendelspod, we talk with Steve McCloskey, founder and CEO of Nanome, the company bri...

Beyond the $100 Genome--the Everyday Sequencing Revolution You Missed: Mark Budde, Plasmidsaurus

29 Apr 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comWait! What? Sequencing as a service?That was the reaction when Mark B...

What Next for LDTs? A Conversation with Sarah Overton of Velsera

22 Apr 2025

Contributed by Lukas

Just weeks before the FDA’s sweeping rule to regulate laboratory-developed tests (LDTs) was set to take effect, a federal court struck it down. What...

AI’s Quiet Revolution in the Pharma Supply Chain with Chris Petersen, Scientist.com

17 Apr 2025

Contributed by Lukas

In today’s show, Theral is joined by Chris Petersen, Chief Technology Officer at Scientist.com, a company sometimes called the "Amazon for science"—...

We've Been Misclassifying Childhood AML for Years: Jeffery Klco, St. Jude's

15 Apr 2025

Contributed by Lukas

In today’s program, we continue our series on disease subtyping with Dr. Jeffery Klco, a pediatric pathologist and researcher at St. Jude Children’...

Aaron Viny: A 21-Year Leukemia Survivor on the Frontlines of Epigenetic Cancer Research

10 Apr 2025

Contributed by Lukas

Dr. Aaron Viny, oncologist and researcher at Columbia University, begins today’s conversation with a personal milestone—he’s now been leukemia-f...

Toward Disease Sub-typing with Ben Busby, DNAnexus

03 Apr 2025

Contributed by Lukas

We’re happy to welcome back Ben Busby, Principal Scientist at DNAnexus, to dive deeper into the evolving world of disease subtyping and multi-omic d...

Synthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John Cumbers

01 Apr 2025

Contributed by Lukas

John Cumbers, founder of SynBioBeta, joins Theral for our annual look ahead at the field of synthetic biology and the upcoming SynBioBeta 2025 confere...

Beyond the Parts List: Chris Mason and Simon Fredriksson on Mapping the Immune System in Space and Cancer with Cell Surface Proteomics

27 Mar 2025

Contributed by Lukas

Today Theral is joined by returning guests Chris Mason of Weill Cornell Medicine and Simon Fredriksson, CEO of Pixelgen Technologies, for a deep dive ...

DNA Is Still Where It's At: Christian Henry, CEO of PacBio, on Watershed Year in 2024

20 Mar 2025

Contributed by Lukas

In our last episode, we explored the growing shift from genomics to multi-omics. But for Pacific Biosciences CEO Christian Henry, the foundation of di...

A New Sequencing Technology Has Entered the World: Keith Robison Reviews AGBT and New Tech in our Annual Sequencing--er, Multi-Omics Show

13 Mar 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIt’s time for our annual deep dive into sequencing—no, wait—mult...

Unlocking the Future of Forensic Genetics with Mirna Ghemrawi

06 Mar 2025

Contributed by Lukas

This week on Mendelspod, as we celebrate International Women’s Day, we’re spotlighting groundbreaking contributions from women in science. Our gue...

Public Science in Peril: Hank Greely of Stanford on Funding, Fishing, and the Fight for Knowledge

04 Mar 2025

Contributed by Lukas

In this urgent and unflinching conversation, Stanford law professor Hank Greely returns to Mendelspod to address the mounting threats of the Trump adm...

Breaking the ‘Undruggable’ Barrier with AI and Synthetic Biology: Eswar Iyer, CEO of Aikium

27 Feb 2025

Contributed by Lukas

For decades, drug developers have struggled with so-called "undruggable" proteins—those regions of the proteome that evade traditional small molecul...

"They're not cutting a branch. They're cutting the whole tree." Laura Hercher Defends DEI in Genomic Research and Medicine

10 Feb 2025

Contributed by Lukas

Today Theral talks with Laura Hercher, Director of Research for Human Genetics at Sarah Lawrence College, about the growing political assault on diver...

Early Detection for Lung Cancer with Susan Tousi, DELFI Diagnostics

06 Feb 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comLung cancer is the most deadly of all the cancers worldwide. Very few ...

Big RNA with Brendan Frey of Deep Genomics

30 Jan 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn our first conversation with Deep Genomics, Theral sits down with Br...

Genome Informatics in the Age of AI With Ben Busby, DNAnexus

23 Jan 2025

Contributed by Lukas

In this Mendelspod episode, Theral explores the state of genome informatics with Ben Busby, principal scientist at DNAnexus.Busby reflects on his jour...

AI & the Future of Genetic Testing: Ezra Cohen, CMO of Tempus

16 Jan 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comAs 2025 begins, we are launching a new series The New Genetic Testing....

PredxBio and the Promise of Spatially Intelligent Biology

10 Jan 2025

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comThis week we welcome the innovative minds behind PredixBio, a new and ...

Surprise: Our Most Popular Show of 2024 Was on Genomic AI

19 Dec 2024

Contributed by Lukas

This year in a series co-produced with GenomeWeb we had an exclusive look into Illumina’s work in genomic AI with Kyle Farh, the VP and Distinguishe...

New Startup Launches Epigenetic Screening: Mohamad Takwa, CEO, Epigenica

05 Dec 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this episode of Mendelspod, Theral sits down with Dr. Mohamad Takwa...

AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina

21 Nov 2024

Contributed by Lukas

Coming from the field of digital pathology, Joachim Schmid has a unique perspective on the evolution of multi-omics.  Schmid was recently appointed a...

Renowned GI Oncologist Discusses MRD Testing and the Future of Cancer Detection

14 Nov 2024

Contributed by Lukas

Dr. Mark Lewis is a well known GI oncologist at Intermountain Health in Salt Lake City, Utah. Gifted with a passionate communication style, he has ove...

Precision Medicine Then and Now: We Talk with the Retiring President of the Personalized Medicine Coalition, Ed Abrahams

12 Nov 2024

Contributed by Lukas

When Bill Clinton announced the sequencing of the human genome in 2000, the New York Times ran the following headline on the front page: "Genetic Code...

MicroRNA: A New Era in Biomarker Discovery with Tim Williams and Paola Ulivi

07 Nov 2024

Contributed by Lukas

In this episode, Theral delves into the groundbreaking role of microRNA as a cancer biomarker with Tim Williams, professor of clinical pathology at th...

Somatic Genomics: A Revolution in Biology with Jacob Rubens

31 Oct 2024

Contributed by Lukas

Jacob Rubens is having quite a career.  Studying at  MIT in the Synthetic Biology Center with Professor Tim Lu, he invented gene circuits that allow...

Exploring the Future of Single Cell Technology with Mauro Muraro, CEO, Single Cell Discoveries

29 Oct 2024

Contributed by Lukas

Human genomics is complex. With new, scalable tools, we are unraveling that complexity. For example, we don’t just each have one genome; we have tri...

Grail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik Bajaj

17 Oct 2024

Contributed by Lukas

Vik Bajaj is bullish on genomics in the age of artificial intelligence. A pioneering figure in biotech—co-founder of Verily and Grail—Bajaj now ...

Singular Genomics Introduces a Dual-Purpose Platform Capable of Both NGS and Spatial Multiomics: Drew Spaventa, CEO & Founder

15 Oct 2024

Contributed by Lukas

Singular Genomics launched its fast and flexible mid-throughput sequencing platform, the G4, in the heady days of the pandemic when we saw a renaissan...

The Evolving Future of Genetic Counseling with Ellen Matloff, CEO, MyGeneCounsel

30 Sep 2024

Contributed by Lukas

Ellen Matloff is back on the show today to discuss the changing landscape of genetic testing and counseling in 2024. She is the founder and CEO of MyG...

As Sequencing Continues to Scale, Volta Labs Improves Sample Prep: Udayan Umapathi, CEO

26 Sep 2024

Contributed by Lukas

Depending on your age, DNA sequencing is experiencing a second or third renaissance. New sequencing tools continue to make genomics one of the fastest...

What’s Next for Large-Scale Proteomics? With Chris Whelan, Janssen

19 Sep 2024

Contributed by Lukas

Genetic studies of human populations have become a major tool for drug development. In the last few years, these studies have moved toward comprehens...

Will this At-Home Blood Collection Device Transform Medicine? Ben Casavant, Tasso

17 Sep 2024

Contributed by Lukas

This is a free preview of a paid episode. To hear more, visit www.mendelspod.comA new blood collection device offered by startup company Tasso is a bl...

Geneticist Kevin Mitchell Attempts to Naturalize Free Will in New Book

12 Sep 2024

Contributed by Lukas

Today, we continue “The New Biology” series with a non-reductive geneticist from Trinity College in Dublin.  Kevin Mitchell is the author of Free...

ctDNA Testing Could Lead to New Ways of Staging Cancer Patients, Says Ben Weinberg, MedStar Georgetown

27 Aug 2024

Contributed by Lukas

Today, we go to the frontlines of cancer treatment for a case study on the use of ctDNA testing in the clinic. ctDNA, or circulating tumor DNA, is no...

14th Season Opener: Michael Levin on ‘The New Biology’

22 Aug 2024

Contributed by Lukas

For over a hundred years, biologists have been working to fully understand biology at the level of chemistry, in other words unite biology with chemis...

The Success of ctDNA Testing in Colorectal Cancer: Adham Jurdi, Natera

20 Aug 2024

Contributed by Lukas

Adham Jurdi was an oncologist at the Austin Cancer Center when the pandemic hit. His cancer patients were a doubly vulnerable population. Office visit...

Henrik Zetterberg on the Current Excitement Around Alzheimer’s Research

14 Aug 2024

Contributed by Lukas

Alzheimer’s disease is now one of the hottest areas of research despite little progress in the decades up to about five years ago. The disease was p...